Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Precigen Inc (NQ: PGEN )

0.9601 +0.0229 (+2.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,809,175
Open 0.9700
Bid (Size) 0.9201 (10)
Ask (Size) 0.9600 (20)
Prev. Close 0.9372
Today's Range 0.9102 - 0.9700
52wk Range 0.9010 - 2.900
Shares Outstanding 206,643,428
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Biotechs are capable of making huge gains in short periods, and they often do. 
Via The Motley Fool

Performance

YTD
-35.13%
-35.13%
1 Month
-19.99%
-19.99%
3 Month
-24.40%
-24.40%
6 Month
-53.84%
-53.84%
1 Year
-53.39%
-53.39%

More News

Read More
Founders at These 7 Companies Are Loading Up on Their Stock. Should You?
Via InvestorPlace
Precigen's Return On Capital Employed Insights
Via Benzinga
Earnings Preview For Precigen
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
3 Penny Stocks The Insiders Are Buying
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week
Via The Motley Fool
Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response
Via Benzinga
Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response
Via News Direct
$20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About
Via Benzinga
Nasdaq Falls 50 Points; eHealth Shares Spike Higher
Via Benzinga
Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings
Via Benzinga
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
US Stocks Open Lower; Dow Dips 250 Points
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
3 Penny Stocks That Could Make You Filthy Rich
Via The Motley Fool
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Intuitive Surgical, Microsoft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Precigen’s Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
Via News Direct
Topics Death
Exposures Death
Precigen’s Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
Via TheNewswire.com
Topics Death
Exposures Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.